Dr. Clayton Lau, chief, Division of Urology and Urologic Oncology at City of Hope, a leading-edge cancer research and treatment organization, discusses how prostate-specific membrane antigen (PSMA) PET scans significantly improve prostate cancer detection and treatment. He talks about single-port robotic prostatectomy that improves recovery time and how prostate surgery is increasingly becoming an outpatient procedure with same-day discharge.
At City of Hope since 2006, Clayton S. Lau, M.D., specializes in minimally invasive approaches to urologic oncology and reconstructive urology. He has performed over 3,500 robotic and laparoscopic procedures. He has also trained numerous surgeons in robotic surgery throughout the U.S. He is an international expert in robotic surgery and has been invited to lecture and perform robotic surgeries internationally.
Dr. Lau is known for the close, professional relationship he establishes with his patients. He goes the extra mile to make sure they know everything they need to know about their urologic malignancy treatment options – and that includes getting a second opinion.
“Second opinions are very important for any patient who has been diagnosed with cancer,” he says. “I see about 20 to 30 second opinion patients per month.”